340 related articles for article (PubMed ID: 32815126)
1. Genetic Transformation of Fusobacterium nucleatum.
Yoshida A; Ikegami A
Methods Mol Biol; 2021; 2210():43-50. PubMed ID: 32815126
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
Brennan CA; Garrett WS
Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
[TBL] [Abstract][Full Text] [Related]
3. Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum.
Peluso EA; Scheible M; Ton-That H; Wu C
Curr Protoc Microbiol; 2020 Jun; 57(1):e104. PubMed ID: 32539234
[TBL] [Abstract][Full Text] [Related]
4. Maternal oral origin of Fusobacterium nucleatum in adverse pregnancy outcomes as determined using the 16S-23S rRNA gene intergenic transcribed spacer region.
Gonzales-Marin C; Spratt DA; Allaker RP
J Med Microbiol; 2013 Jan; 62(Pt 1):133-144. PubMed ID: 23002071
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum - Friend or foe?
Stokowa-Sołtys K; Wojtkowiak K; Jagiełło K
J Inorg Biochem; 2021 Nov; 224():111586. PubMed ID: 34425476
[TBL] [Abstract][Full Text] [Related]
6. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
8. Sonoporation is an efficient tool for intracellular fluorescent dextran delivery and one-step double-crossover mutant construction in Fusobacterium nucleatum.
Han YW; Ikegami A; Chung P; Zhang L; Deng CX
Appl Environ Microbiol; 2007 Jun; 73(11):3677-83. PubMed ID: 17449701
[TBL] [Abstract][Full Text] [Related]
9.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
11. More Than Just a Periodontal Pathogen -the Research Progress on
Chen Y; Huang Z; Tang Z; Huang Y; Huang M; Liu H; Ziebolz D; Schmalz G; Jia B; Zhao J
Front Cell Infect Microbiol; 2022; 12():815318. PubMed ID: 35186795
[No Abstract] [Full Text] [Related]
12. Determination of the Role of Fusobacterium Nucleatum in the Pathogenesis in and Out the Mouth.
Tefiku U; Popovska M; Cana A; Zendeli-Bedxeti L; Recica B; Spasovska-Gjorgovska A; Spasovski S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2020 Jun; 41(1):87-99. PubMed ID: 32573481
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
[TBL] [Abstract][Full Text] [Related]
14. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
Castellarin M; Warren RL; Freeman JD; Dreolini L; Krzywinski M; Strauss J; Barnes R; Watson P; Allen-Vercoe E; Moore RA; Holt RA
Genome Res; 2012 Feb; 22(2):299-306. PubMed ID: 22009989
[TBL] [Abstract][Full Text] [Related]
16. Differences in mortality in Fusobacterium necrophorum and Fusobacterium nucleatum infections detected by culture and 16S rRNA gene sequencing.
Johannesen KM; Kolekar SB; Greve N; Nielsen XC; Barfod TS; Bodtger U
Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):75-80. PubMed ID: 30374684
[TBL] [Abstract][Full Text] [Related]
17. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
18. Isolation and molecular identification of Fusobacterium nucleatum from Nigerian patients with oro-facial infections.
Nwaokorie FO; Coker AO; Ogunsola FT; Avika-Campos MJ; Gaetti-Jardim E; Ayanbadejo PO; Umeizudike KA; Abdurrazaq OT
West Afr J Med; 2011; 30(2):125-9. PubMed ID: 21984462
[TBL] [Abstract][Full Text] [Related]
19. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
